Overview

BRCA1-associated DNA Repair Dysfunction in Patients With Early Triple Negative Breast Cancer Treated With Neoadjuvant Platinum-based Chemotherapy

Status:
Completed

Trial end date:
2015-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess efficacy of platinum-based neoadjuvant chemotherapy in correlation with BRCA1-associated DNA repair dysfunction in patients with early triple negative breast cancer.

Phase:

Phase 2

Details

Lead Sponsor:

Russian Academy of Medical Sciences

Treatments:

Albumin-Bound Paclitaxel
Cisplatin
Doxorubicin
Liposomal doxorubicin
Paclitaxel